Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Revvity
RVTY
$12.3B
| $425M | 0.27% |
6,161,489
-244,187
| -4% | -$16.4M |
|
102
MSCI
MSCI
$40B
| $420M | 0.27% |
3,594,478
-200,146
| -5% | -$22.2M |
|
103
Air Products & Chemicals
APD
$66.3B
| $420M | 0.27% |
2,774,243
+54,048
| +2% | +$7.92M |
|
104
Verisk Analytics
VRSK
$26.4B
| $418M | 0.27% |
5,024,212
-478,635
| -9% | -$39.7M |
|
105
HEICO Corp Class A
HEI.A
$35.4B
| $414M | 0.27% |
8,489,203
-345,672
| -4% | -$15.8M |
|
106
Belden
BDC
$4B
| $409M | 0.26% |
5,072,653
+174,365
| +4% | +$13.2M |
|
107
Nice
NICE
$5.29B
| $407M | 0.26% |
5,006,620
-44,123
| -0.9% | -$3.43M |
|
|
108
Cimpress
CMPR
$2.37B
| $398M | 0.26% |
+4,079,832
| New | +$379M |
|
109
PepsiCo
PEP
$186B
| $398M | 0.25% |
3,567,586
+659,663
| +23% | +$76.2M |
|
110
Pfizer
PFE
$140B
| $396M | 0.25% |
11,701,206
-2,185,441
| -16% | -$70.2M |
|
111
Procter & Gamble
PG
$343B
| $392M | 0.25% |
4,305,492
-195,072
| -4% | -$17.8M |
|
112
Automatic Data Processing
ADP
$100B
| $390M | 0.25% |
3,563,824
-450,041
| -11% | -$48.2M |
|
113
Thermo Fisher Scientific
TMO
$211B
| $377M | 0.24% |
1,993,597
-348,449
| -15% | -$63.1M |
|
114
Zoetis
ZTS
$31.6B
| $376M | 0.24% |
5,893,853
+84,767
| +1% | +$5.31M |
|
115
3M
MMM
$89B
| $376M | 0.24% |
2,139,695
+528,705
| +33% | +$91.6M |
|
116
Cisco
CSCO
$450B
| $373M | 0.24% |
11,102,708
-2,425,351
| -18% | -$77.2M |
|
117
Ametek
AME
$55.5B
| $372M | 0.24% |
5,639,602
-764,068
| -12% | -$48.3M |
|
|
118
IQVIA
IQV
$34.7B
| $372M | 0.24% |
3,909,348
-2,622,509
| -40% | -$243M |
|
|
SCHW
119
Charles Schwab
SCHW
$177B
| $370M | 0.24% |
8,463,696
-894,040
| -10% | -$37.1M |
|
120
Philip Morris
PM
$301B
| $370M | 0.24% |
3,328,836
+1,541,007
| +86% | +$179M |
|
121
Waste Management
WM
$95.9B
| $367M | 0.24% |
4,684,275
+366,450
| +8% | +$27.8M |
|
122
Zurn Elkay Water Solutions
ZWS
$8.07B
| $360M | 0.23% |
29,432,502
+1,532,355
| +5% | +$17.8M |
|
|
VAR
123
DELISTED
Varian Medical Systems, Inc.
VAR
| $354M | 0.23% |
3,538,817
-215,910
| -6% | -$22.2M |
|
124
Ryanair
RYAAY
$29.5B
| $353M | 0.23% |
8,361,640
-155,428
| -2% | -$7.02M |
|
125
Waters Corp
WAT
$36.8B
| $352M | 0.23% |
1,959,850
+30,057
| +2% | +$5.45M |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.